Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 127 of 155
-
Citation: Arthritis Res Ther 2004 6(Suppl 1):106
-
The role of a defective clearance in the pathogenesis of systemic lupus erythematosus
Citation: Arthritis Res Ther 2004 6(Suppl 1):104 -
Three-dimensional power Doppler sonographic visualization of synovial vasculature: an 'in vivo' model to study angiogenesis in rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):102 -
Statins have no effect on collagen-induced arthritis in mice
Citation: Arthritis Res Ther 2004 6(Suppl 1):100 -
Cross-reaction between the major epitope of Ro60 protein (pep216–232) and a homologous peptide of Coxsackievirus 3C protease
Citation: Arthritis Res Ther 2004 6(Suppl 1):96 -
Multidrug resistance proteins and DMARD efficacy in rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):87 -
Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):85 -
Application of regulatable vectors in gene therapy of experimental arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):83 -
IL-22 gene transfer in collagen-induced arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):81 -
Switching of serotype can improve local AAV-mediated gene therapy in RA
Citation: Arthritis Res Ther 2004 6(Suppl 1):79 -
Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence for the existence of distinctive pathways relevant to disease
Citation: Arthritis Res Ther 2004 6(Suppl 1):77 -
Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):75 -
B lymphocytes infiltrating Wegener's granuloma: the immunoglobulin VH gene repertoire from granulomatous tissues displays an antigen-driven maturation and suggests a microbial trigger
Citation: Arthritis Res Ther 2004 6(Suppl 1):74 -
Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):72 -
Reporter cell lines for real-time imaging of NF-κB activation in the arthritic joint
Citation: Arthritis Res Ther 2004 6(Suppl 1):70 -
Monocyte-specific gene signatures in rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):68 -
Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
Citation: Arthritis Res Ther 2004 6(Suppl 1):66 -
Histochemical detection of oxidative stress in synovial tissue: spontaneous reactive oxygen species (ROS) production by rheumatoid arthritis T cells
Citation: Arthritis Res Ther 2004 6(Suppl 1):64 -
Protection of inflammation-related bone loss by OPG and TNF-α antibodies through distinct mechanisms in collagen-induced arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):62 -
Expression of TRAIL-R2 (DR5) on fibroblasts from synovial fluid of rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):60 -
Requirement of local synovial IL-17 receptor signaling in the progression of chronic synovitis and bone erosion in arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):58 -
Human bone marrow-derived mesenchymal stem cells: studies on chondrogenic differentiation, chemotaxis and recruitment
Citation: Arthritis Res Ther 2004 6(Suppl 1):57 -
Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis
Citation: Arthritis Res Ther 2004 6(Suppl 1):55 -
Differential gene expression and protein expression levels of MMP and TIMP molecules in response to glucocorticoid treatment in arthritic patients
Citation: Arthritis Res Ther 2004 6(Suppl 1):53 -
The effects of NF-κB inhibition by a NEMO binding domain peptide in vitro and in vivo
Citation: Arthritis Res Ther 2004 6(Suppl 1):51 -
Phenotypic and functional deficiencies of monocyte derived dendritic cells in systemic lupus erythematosus patients
Citation: Arthritis Res Ther 2004 6(Suppl 1):49 -
Differential dendritic cell expression in chronic inflammatory arthritis: implications for their maturation, recruitment and involvement in disease
Citation: Arthritis Res Ther 2004 6(Suppl 1):47 -
RANK and RANKL expression in rheumatoid arthritis synovium and lymph nodes as markers of dendritic cell – T cell interactions
Citation: Arthritis Res Ther 2004 6(Suppl 1):45 -
Increased expression of chemokines DC-CK1, ELC and TARC by dendritic cells and in synovium from patients with rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):43 -
CD25+regulatory T cells can be used therapeutically in collagen-induced arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):40 -
Autoreactive T cells specific for a natural intracellular hapten: an example from patients with acute myocarditis and possible consequences for other inflammatory diseases
Citation: Arthritis Res Ther 2004 6(Suppl 1):38 -
Influence of the physicochemical properties of the HLA-DRB1 shared epitope negative alleles on rheumatoid arthritis susceptibility
Citation: Arthritis Res Ther 2004 6(Suppl 1):36 -
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):34 -
Overexpression of TNF causes bilateral sacroiliitis
Citation: Arthritis Res Ther 2004 6(Suppl 1):32 -
IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17
Citation: Arthritis Res Ther 2004 6(Suppl 1):30 -
Intra-articular steroid treatment reduces synovial HMGB1 but not IL-1 expression in chronic arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):28 -
Cross-talk between TRAIL and TGF-β in regulation of collagen production in scleroderma lung disease
Citation: Arthritis Res Ther 2004 6(Suppl 1):26 -
Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
Citation: Arthritis Res Ther 2004 6(Suppl 1):24 -
Elevated expression of IL-18 in Sjögren's syndrome: distinct expression patterns of the active and proactive forms
Citation: Arthritis Res Ther 2004 6(Suppl 1):22 -
The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):20 -
Citrullinated proteins in arthritis: presence in joints and effects on immunogenicity
Citation: Arthritis Res Ther 2004 6(Suppl 1):18 -
False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
Citation: Arthritis Res Ther 2004 6(Suppl 1):16 -
VIDAS-EDRA fully automated testing of autoantibodies to citrullinated proteins for the diagnosis of rheumatoid arthritis
Citation: Arthritis Res Ther 2004 6(Suppl 1):14 -
Two B cell populations differentially expressing IgVH mRNAs in human RA synovium
Citation: Arthritis Res Ther 2004 6(Suppl 1):12 -
Immune complexes from RA patients induce FcγRII-dependent and RF-correlated TNF-α and IL-8 production from healthy PBMC
Citation: Arthritis Res Ther 2004 6(Suppl 1):10 -
Multiplex analysis of antinuclear antibodies by flow cytometry using FIDIS
Citation: Arthritis Res Ther 2004 6(Suppl 1):8 -
Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus
Citation: Arthritis Res Ther 2004 6(Suppl 1):6 -
Concomitant appearance of anti-cardiolipin, anti-β2-glycoprotein I, anti-prothrombin and anti-annexin V antibodies
Citation: Arthritis Res Ther 2004 6(Suppl 1):4 -
Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
Citation: Arthritis Res Ther 2004 6(Suppl 1):3 -
Differential antibody recognition of the 349–364aa B-cell epitope of human La/SSB protein and its phosphorylated analogue
Citation: Arthritis Res Ther 2004 6(Suppl 1):1